BLUEJAY THERAPEUTICS, INC.

Profile

Company Names

BLUEJAY THERAPEUTICS, INC.

Addresses

400 CONCAR DRIVE, SUITE 3-101, SAN MATEO, CA 94402

951 MARINERS ISLAND BLVD., SUITE 300, SAN MATEO, CA 94404

45 FALKIRK LANE, HILLSBOROUGH, CA 94010

Phone Numbers

650-218-5487
6502185487

 

Entity Type:

CORPORATION

Industry:

OTHER TECHNOLOGY

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$221,739,912.00

Number of Funding Rounds:

3
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
3
2024-05-01 
$181,999,946.00 
$181,999,946.00 
$0.00 
Equity 
2
2022-08-09 
$20,499,976.00 
$41,150,200.00 
$20,650,224.00 
Equity 
1
2021-06-10 
$19,239,990.00 
$24,239,991.00 
$5,000,001.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
WEN 
 
CHEN 
DIRECTOR
ULTIVUE, INC.   |  MESA BIOTECH, INC.   |  HISTOSONICS, INC.   |  GOLDFINCH BIO, INC.   |  BLUEJAY THERAPEUTICS, INC.   |  SIGMOID CAPITAL OFFSHORE FUND LTD
KETING 
 
CHU 
EXECUTIVE OFFICER, DIRECTOR
AIHC (US FEEDER) FUND   |  TEMPEST THERAPEUTICS, INC.   |  BLUEJAY THERAPEUTICS, INC.
DAN 
 
ESTES 
DIRECTOR
RADIONETICS ONCOLOGY, INC.   |  BLUEJAY THERAPEUTICS, INC.   |  EYCONIS, INC.
NANCY 
 
HONG 
DIRECTOR
SCOUT BIO, INC.   |  XILIO THERAPEUTICS, INC.   |  SEQURE DX INC.   |  BIOLINQ INC   |  BLUEJAY THERAPEUTICS, INC.
TING 
 
JIA 
DIRECTOR
ANTIVA BIOSCIENCES, INC.   |  OCTAGON INVESTMENTS FUND LP   |  OCTAGON INVESTMENTS OFFSHORE FUND LTD.   |  OCTAGON PRIVATE OPPORTUNITIES FUND LP   |  OCTAGON PRIVATE OPPORTUNITIES OFFSHORE FUND LP   |  OCTAGON SPECIAL OPPORTUNITIES FUND LP -- SERIES 1   |  OCTAGON SPECIAL OPPORTUNITIES FUND LP -- SERIES 2   |  OCTAGON SPECIAL OPPORTUNITIES FUND LP -- SERIES 3   |  NIKANG THERAPEUTICS, INC.   |  OCTAGON SPECIAL OPPORTUNITIES FUND LP -- SERIES 4   |  OCTAGON SPECIAL OPPORTUNITIES FUND LP -- SERIES WU   |  ANBIO THERAPEUTICS LTD.   |  BLUEJAY THERAPEUTICS, INC.   |  OCTAGON PRIVATE OPPORTUNITIES FUND II LP   |  OCTAGON PRIVATE OPPORTUNITIES OFFSHORE FUND II LP
PASCAL 
 
KROTEE 
DIRECTOR
ACTUATE THERAPEUTICS, INC.   |  NOVOSTEO INC.   |  BLUEJAY THERAPEUTICS, INC.
ALON 
 
LAZARUS 
DIRECTOR
KEROS THERAPEUTICS, INC.   |  ONCORUS, INC.   |  WEREWOLF THERAPEUTICS, INC.   |  AURON THERAPEUTICS, INC.   |  BLUEJAY THERAPEUTICS, INC.   |  REUNION NEUROSCIENCE MANAGEMENT, INC.   |  ENTACT BIO, INC.   |  REUNION NEUROSCIENCE, INC.   |  CROSSBOW THERAPEUTICS, INC.
JIANQING 
 
LI 
DIRECTOR
BLUEJAY THERAPEUTICS, INC.
WILLIAM 
J. 
RUTTER 
DIRECTOR
BOSTON BIOMEDICAL INC   |  PROLYNX, INC.   |  NOVOSTEO INC.   |  BLUEJAY THERAPEUTICS, INC.
DAJUN 
 
YANG 
DIRECTOR
BLUEJAY THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-05-10
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-05-01 
2022-08-16
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-08-09 
2021-06-21
D
Link
OTHER TECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-06-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#